Optimus launches COVID-19 drug Favipiravir, commences commercial export
The drug is being marketed under the brand name Favicovid both in India and other countries
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
Safe and effective vaccination should be given high priority: EMA
The two ICMRA statements aim to reassure healthcare professionals and the public around the globe that medicines regulators only…
Sanofi Pasteur launches VaxLine in India
It is a tele-counselling facility with a toll-free number that registers a parent's missed call and allows a VaxLine health expert…
ICT, Lasa succeed in Favipiravir drug synthesis, to commence production
The collaborators aim to manufacture close to 10,000 doses of the antiviral to begin with
Show me the data: US doctors skeptical of reported COVID breakthrough, dexamethasone
Trial results announced showed dexamethasone, used to fight inflammation in other diseases, reduced death rates by around a third…
WHO moves to update COVID-19 guidance after ‘great news’ in dexamethasone study
Trial results announced showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death…
COVID-19 disruption of clinical trials starting to slow: GlobalData
FDA issued guidance recommends methods that could help keep the research going which includes virtual visits, phone interviews,…
Cadila Pharma launches a range of hand sanitizers
The sanitizers contain 70 per cent IPA as per the recommended guidelines by WHO
Curcumin could benefit in COVID-19 treatment: Researchers
A recent peer- reviewed scientific article co-authored by the Founder and Chairman of Sami-Sabinsa Group, Dr Muhammed Majeed,…
Fermenta Biotech and Indchemie pledge Vitamin D3 (DV 60K) for 250,000 Maharashtra Police personnel
The initiative will be a part of the Joint Corporate Social Responsibility programme of Fermenta, India’s only manufacturer of…